Medical Tubing and Extrusion

Medical tubing and extrusion technologies

FDA approves Medtronic’s In.Pact 018 drug-coated balloon catheter

By

Medtronic In.Pact 018 drug-coated balloon catheter
Medtronic’s In.Pact 018 DCB. [Image from Medtronic]
Medtronic (NYSE:MDT) announced that it received FDA approval for its In.Pact 018 paclitaxel-coated balloon catheter.

Fridley, Minnesota–based Medtronic’s In.Pact 018 paclitaxel-coated percutaneous transluminal angioplasty (PTA) balloon catheter, a drug-coated balloon product, received an indication for the interventional treatment of peripheral arterial disease (PAD) in the superficial femoral and popliteal arteries.

Get the full story at our sister site, Drug Delivery Business News.

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].